G06 : A randomized, double-blind, placebo-controlled phase III trial of TSU-68 (orantinib) combined with transcatheter arterial chemoembolization in patients with unresectable hepatocellular carcinoma

Phase Iii ◽

Double Blind ◽

Phase Iii Trial ◽

Double Blind Placebo ◽

Dexamethasone for the prevention of transcatheter arterial chemoembolization-induced fever, nausea, vomiting, and anorexia in patients with hepatocellular carcinoma: A randomized, double-blind, placebo-controlled trial.

Journal of Clinical Oncology ◽

10.1200/jco.2016.34.15_suppl.4071 ◽

2016 ◽

Vol 34 (15_suppl) ◽

pp. 4071-4071

Author(s):

Sadahisa Ogasawara ◽

Tetsuhiro Chiba ◽

Yoshihiko Ooka ◽

Eiichiro Suzuki ◽

Naoya Kanogawa ◽

...

Keyword(s):

Controlled Trial ◽

Double Blind ◽

Double Blind Placebo ◽

Faculty Opinions recommendation of Efficacy and safety of tocilizumab in patients with systemic-onset juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled, withdrawal phase III trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1146988.604098 ◽

2009 ◽

Author(s):

Frank Pessler

Keyword(s):

Juvenile Idiopathic Arthritis ◽

Phase Iii ◽

Efficacy And Safety ◽

Double Blind ◽

Phase Iii Trial ◽

Double Blind Placebo ◽

Withdrawal Phase ◽

Systemic Onset

Faculty Opinions recommendation of Tanezumab reduces osteoarthritic hip pain: results of a randomized, double-blind, placebo-controlled phase III trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717996902.793477633 ◽

2013 ◽

Author(s):

Virginia Kraus

Keyword(s):

Hip Pain ◽

Phase Iii ◽

Double Blind ◽

Phase Iii Trial ◽

Double Blind Placebo

Transcatheter arterial infusion chemotherapy with cisplatin in combination with transcatheter arterial chemoembolization decreases intrahepatic distant recurrence of unresectable hepatocellular carcinoma

JGH Open ◽

10.1002/jgh3.12573 ◽

2021 ◽

Author(s):

Naoto Kawabe ◽

Senju Hashimoto ◽

Takuji Nakano ◽

Kazunori Nakaoka ◽

Aiko Fukui ◽

...

Keyword(s):

Distant Recurrence ◽

Arterial Infusion ◽

Arterial Infusion Chemotherapy ◽

Infusion Chemotherapy ◽

Transcatheter Arterial Infusion ◽

Transcatheter Arterial Infusion Chemotherapy ◽

Efficacy of an oral contraceptive containing EE 0.03 mg and CMA 2 mg (Belara®) in moderate acne resolution: a randomized, double-blind, placebo-controlled Phase III trial

Contraception ◽

10.1016/j.contraception.2009.02.016 ◽

2009 ◽

Vol 80 (1) ◽

pp. 25-33 ◽

Cited By ~ 27

Author(s):

Gerd Plewig ◽

William J. Cunliffe ◽

Natascha Binder ◽

Kornelia Höschen

Keyword(s):

Oral Contraceptive ◽

Phase Iii ◽

Double Blind ◽

Phase Iii Trial ◽

Double Blind Placebo

Rituximab for rheumatoid arthritis refractory to anti–tumor necrosis factor therapy: Results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial evaluating primary efficacy and safety at twenty-four weeks

Arthritis & Rheumatism ◽

10.1002/art.22025 ◽

2006 ◽

Vol 54 (9) ◽

pp. 2793-2806 ◽

Cited By ~ 1041

Author(s):

Stanley B. Cohen ◽

Paul Emery ◽

Maria W. Greenwald ◽

Maxime Dougados ◽

Richard A. Furie ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Tumor Necrosis ◽

Phase Iii ◽

Primary Efficacy ◽

Efficacy And Safety ◽

Double Blind ◽

Phase Iii Trial ◽

Double Blind Placebo ◽

Factor Therapy ◽

Necrosis Factor

RESPONSE: Re: Double-Blind, Placebo-Controlled, Randomized Phase III Trial of Darbepoetin Alfa in Lung Cancer Patients Receiving Chemotherapy

JNCI Journal of the National Cancer Institute ◽

10.1093/jnci/95.10.762 ◽

2003 ◽

Vol 95 (10) ◽

pp. 762-763

Author(s):

J. F. Vansteenkiste ◽

A. B. Colowick

Keyword(s):

Lung Cancer ◽

Cancer Patients ◽

Darbepoetin Alfa ◽

Phase Iii ◽

Double Blind ◽

Phase Iii Trial ◽

Double Blind Placebo ◽

Lung Cancer Patients

The Degree of Lipiodol Accumulation Can Be an Indicator of Successful Treatment for Unresectable Hepatocellular Carcinoma (HCC) Patients - in the Case of Transcatheter Arterial Chemoembolization (TACE) and External Beam Radiotherapy (EBRT)

Journal of Cancer ◽

10.7150/jca.15405 ◽

2016 ◽

Vol 7 (11) ◽

pp. 1413-1420 ◽

Cited By ~ 5

Author(s):

Ping Yang ◽

Zhao-Chong Zeng ◽

Bin-Liang Wang ◽

Jian-Ying Zhang ◽

Jia Fan ◽

...

Keyword(s):

Successful Treatment ◽

External Beam Radiotherapy ◽

External Beam ◽

Transcatheter arterial chemoembolization in combination with radiotherapy for unresectable hepatocellular carcinoma: A systematic review and meta-analysis

Radiotherapy and Oncology ◽

10.1016/j.radonc.2008.11.002 ◽

2009 ◽

Vol 92 (2) ◽

pp. 184-194 ◽

Cited By ~ 92

Author(s):

Mao-Bin Meng ◽

Yao-Li Cui ◽

You Lu ◽

Bin She ◽

Yan Chen ◽

...

Keyword(s):

Systematic Review ◽

Meta Analysis ◽

RIBBON-1: Randomized, Double-Blind, Placebo-Controlled, Phase III Trial of Chemotherapy With or Without Bevacizumab for First-Line Treatment of Human Epidermal Growth Factor Receptor 2–Negative, Locally Recurrent or Metastatic Breast Cancer

Yearbook of Oncology ◽

10.1016/j.yonc.2011.08.001 ◽

2011 ◽

Vol 2011 ◽

pp. 33-34

Author(s):

J.T. Thigpen

Keyword(s):

Growth Factor Receptor ◽

Metastatic Breast ◽

Phase Iii ◽

First Line ◽

Double Blind ◽

Phase Iii Trial ◽

Double Blind Placebo ◽

Epidermal Growth ◽

Locally Recurrent ◽

First Line Treatment